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I am grateful to the Editor for the opportunity of responding to the recent paper of Burstyn and
De Roos [1], that is in part, a critical commentary of my own analysis of data from the US Agricultural
Health Study (AHS) concerning the findings for multiple myeloma and glyphosate use [2].
Firstly, I agree with Burstyn and De Roos that the more important findings from any
epidemiological study are those relating to levels of estimated or measured exposure (so-called
dose-response analyses) rather than simple ever/never exposed comparisons. That is why, in my own
analyses, I showed the results of eight dose-response analyses; none was statistically significant and
most were a long way from being statistically significant. So why did I also put some considerable
effort into working out whether there was any basis for preferring one of the two findings supplied by
De Roos et al. [3] for ever-use of glyphosate? [3]: Rate ratio (RR) of 1.1, 95% Confidence Interval (CI)
0.5 to 2.4, in full dataset adjusted for age only; RR of 2.6, 95% CI 0.7 to 9.4, in restricted dataset with
adjustment for many variables. It is because one could be reasonably confident that one or other of
these values would be used in future meta-analyses that would, by necessity, be limited to making
use of these simplistic overall findings. It would, therefore, be important to know which estimate
could be relied upon. I have checked the logic and language in my original paper and my conclusion
that the risk estimate of 2.6 arose from the use of a restricted dataset that, probably by chance, turned
out to be unrepresentative, is correct, polite and fair. Burstyn and De Roos [1] would appear to agree
with this when they state ‘there is likely selection bias adversely affecting the analysis with ever- vs.
never-exposed.’
Burstyn and De Roos [1] are concerned about relying on ‘intuition’, and sole reliance on any
single skill or aptitude is probably dangerous. But on first reading of the De Roos et al. paper [3] more
than ten years ago, I strongly suspected that something very odd must be going on to produce such
disparate findings for ever-use of glyphosate. Whether that is intuition or experience is a moot point.
Finally, I fully agree with Burstyn and De Roos [1] that an updated AHS needs to be analysed.
The pesticide applicators that are participating in this key survey are stakeholders. Can’t they make
representations to bring such an analysis about?
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